DSPACE
LIVE

Serial Number

79367887

Owner

DAIICHI SANKYO EUROPE GmbH

Attorney

Douglas R. Wolf

Filing Date

Sep 23, 2022

Add to watchlist:

No watchlists yet
View on USPTO

DSPACE Trademark

Serial Number: 79367887 • Registration: 7445275

DSPACE is a trademark filed by DAIICHI SANKYO EUROPE GmbH on September 23, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

DAIICHI SANKYO EUROPE GmbH (3 trademarks)

Zielstattstr. 48

Entity Type: 99

Trademark Details

Filing Date

September 23, 2022

Registration Date

July 16, 2024

Published for Opposition

April 30, 2024

Goods & Services

Pharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, psychiatric diseases and disorders, gastrointestinal diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases; sanitary preparations for medical purposes; dietetic foods adapted for medical and veterinary purposes, food for babies; dietary supplements for human beings and animals; medical plasters, materials for dressings, namely, medical dressings; disinfectants; medicinal healthcare preparations, namely, biological preparations for the treatment of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, psychiatric diseases and disorders, gastrointestinal diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases * ; the aforesaid goods solely aimed at those involved in a healthcare system, namely healthcare service recipients, namely patients, healthcare service providers, namely doctors, healthcare service financers/healthcare service payers, namely insurance providers, in the field of digital health *

Medical services; consulting services relating to health care, namely, consulting in the field of healthcare; health counselling; providing health assessment services in the nature of health assessment surveys; providing health information; health assessment services; information services relating to health care; human healthcare services; health clinic services; health resort services, namely, health care services for wellness of the mind, body and spirit; managed health care services; home health care services; provision of health information; medical health assessment services; medical and healthcare services; health advice and information services; health care consultancy services; rental of medical and health care equipment; health care services offered through a network of health care providers on a contract basis; preparation of reports relating to health care matters; providing health care information via a global computer network; medical information; medical counseling; medical consultations; medical examinations; medical care; medical diagnostic services; providing medical physical evaluation services; medical equipment rental; rental of equipment, namely, rental of medical equipment; advisory services relating to medical problems; telemedicine services; providing medical information in the healthcare sector; providing on-line information relating to the prevention of cardiovascular disease and strokes; medical screening services relating to cardiovascular disease; providing information relating to the treatment of cardiovascular and cerebrovascular diseases via the internet; personalised health care and medical care; providing information to patients in the field of administering medications and medical and health care services through the use of software being telemedicine services; provision of health care support services for patients, namely, drug reminders being interactive medical monitoring and alert service for reminding clients of medicinal dosage, allergic sensitivity, and prescription refills for treatment purposes, nutrition consulting; information relating to the use of medicines * ; the aforesaid services solely aimed at those involved in a healthcare system, namely healthcare service recipients, namely patients, healthcare service providers, namely doctors, healthcare service financers/healthcare service payers, namely insurance providers, in the field of digital health *

Surgical apparatus and instruments; therapeutic and assistive devices adapted for persons with disabilities, namely, body rehabilitation apparatuses for medical purposes; testing apparatus for medical purposes, namely, blood testing apparatus; diagnostic apparatus, namely, apparatus for the detection, diagnosis, and treatment of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, psychiatric diseases and disorders, gastrointestinal diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases for medical purposes; electronic apparatus for medical purposes, namely, electronic stimulation apparatus for nerves, skin, and muscles for physical therapy purposes; medical imaging apparatus; electronic medical instruments, namely, electronic medical appliances for performing surgery; medical diagnostic apparatus for medical purposes, namely, ultrasound and x-ray diagnostic apparatuses * ; the aforesaid goods solely aimed at those involved in a healthcare system, namely healthcare service recipients, namely patients, healthcare service providers, namely doctors, healthcare service financers/healthcare service payers, namely insurance providers, in the field of digital health *

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Dec 18, 2025 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 4, 2025 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 17, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 27, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 27, 2024 FIMP
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Nov 26, 2024 NURC
LIMITATION FROM THE IB EXAMINED AND ENTERED
Nov 5, 2024 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Nov 4, 2024 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 4, 2024 APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 4, 2024 APRE
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 17, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 16, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2024 R.PR
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2024 R.PR
LIMITATION OF GOODS RECEIVED FROM IB
Jul 7, 2024 LIMG
NOTIFICATION PROCESSED BY IB
Apr 30, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 30, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 10, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 10, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 10, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 22, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 22, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 22, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 22, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 22, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 20, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 20, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 5, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 17, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 17, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 18, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jul 17, 2023 CNRT
ASSIGNED TO EXAMINER
Jul 8, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 25, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 21, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 20, 2023 REPR